Case Report: Combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16-positive squamous cell carcinoma of unknown primary

BACKGROUND: Cancer of unknown primary (CUP) is a malignant tumor without a known primary lesion with a frequency of 3−5%. It can be divided into favorable and unfavorable prognosis subsets. While recommended treatments are available for the former group, there is no established treatment for the lat...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Risako, Hamada, Kazuyuki, Ohkuma, Ryotaro, Homma, Mayumi, Tsurui, Toshiaki, Iriguchi, Nana, Ishiguro, Tomoyuki, Hirasawa, Yuya, Ariizumi, Hirotsugu, Kubota, Yutaro, Horiike, Atsushi, Yoshimura, Kiyoshi, Wada, Satoshi, Yamochi, Toshiko, Tsunoda, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365966/
https://www.ncbi.nlm.nih.gov/pubmed/37496666
http://dx.doi.org/10.3389/fonc.2023.1231986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365966/
https://www.ncbi.nlm.nih.gov/pubmed/37496666
http://dx.doi.org/10.3389/fonc.2023.1231986

Ejemplares similares